Ian L. Fox

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Supplementary Materials and Methods, Supplementary 1-7 and Supplementary Table 1. from ERK Inhibition Improves Anti–PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma”.

Supplementary Materials and Methods, Supplementary 1-7 and Supplementary Table 1. from ERK Inhibition Improves Anti–PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma

(2023)10.1158/1535-7163.22520551

N/A

0DataRank · unranked

0 citations

Kyeara N. Mack, Veronica L. Nagle, Mike Cornejo, Adam O. Michel, Ian L. Fox +5 more

Supplementary Materials and Methods, Supplementary 1-7 and Supplementary Table 1. from ERK Inhibition Improves Anti–PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma

Figshare(2023)10.1158/1535-7163.22520551.v1

N/A

0DataRank · unranked

0 citations

Kyeara N. Mack, Veronica L. Nagle, Mike Cornejo, Adam O. Michel, Ian L. Fox +5 more